Rasuvo 10mg/0.2ml Pf Inj, 4 Pens
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered via injection into the fatty tissue of the skin, typically on the top of the thigh or in the belly area. If you will be self-administering the injection, your doctor or nurse will provide guidance on the proper technique.
Important Administration Guidelines
Do not inject the medication within 2 inches (5 cm) of the belly button.
Check the solution for cloudiness, leakage, or particles before use. If any of these conditions are present, do not use the medication.
Avoid injecting into skin that is irritated, tender, bruised, red, scaly, hard, scarred, or has stretch marks.
If you are unsure whether a dose was injected correctly or experience difficulty administering the dose, consult your doctor or pharmacist before proceeding with another dose.
Safe Disposal of Needles and Supplies
Dispose of used needles in a designated needle/sharp disposal box.
Do not reuse needles or other items.
When the disposal box is full, follow local regulations for proper disposal.
If you have any questions or concerns, consult your doctor or pharmacist.
Dosing and Frequency
Your dosage and frequency of administration will be determined by your doctor based on the specific health condition being treated.
Important: This medication should never be taken daily unless prescribed for certain types of cancer. Incorrect use of this medication can lead to serious errors. Ensure you understand your dosage and administration schedule. If you are unsure, consult your doctor.
Your doctor may adjust the dosage or administration schedule based on blood work results, side effects, and the medication's effectiveness.
Handling and Storage
Handle this medication with care. Consult your doctor or pharmacist for guidance on proper handling procedures.
Store the medication at room temperature, protected from light and moisture. Do not store in a bathroom.
Hydration
Drink plenty of non-caffeinated liquids unless your doctor advises you to limit fluid intake.
Storage and Disposal
Store the medication at room temperature, protected from light and moisture. Do not store in a bathroom.
Missed Dose
If you miss a dose, contact your doctor for guidance on what to do next.
Lifestyle & Tips
- Take exactly as prescribed, usually once a week on the same day. Do NOT take daily.
- Take folic acid supplementation as directed by your doctor to reduce side effects (e.g., mouth sores, nausea).
- Avoid alcohol completely or limit intake significantly due to increased risk of liver damage.
- Avoid prolonged sun exposure and use sunscreen/protective clothing, as methotrexate can increase sun sensitivity.
- Report any signs of infection (fever, chills, sore throat) immediately.
- Report any unusual bleeding or bruising.
- Report any new or worsening cough or shortness of breath.
- Avoid live vaccines while on methotrexate.
- Use effective birth control during treatment and for at least 6 months after stopping for both men and women, as it can cause severe birth defects.
Available Forms & Alternatives
Available Strengths:
- Rasuvo 10mg/0.2ml Pf Inj, 4 Pens
- Rasuvo 12.5mg/0.25ml Pf Inj, 4 Pens
- Rasuvo 22.5mg/0.45ml Pf Inj, 4 Pens
- Rasuvo 25mg/0.5ml Pf Inj, 4 Pens
- Rasuvo 15mg/0.3ml Pf Inj, 4 Pens
- Rasuvo 17.5mg/0.35ml Pf Inj, 4 Pens
- Rasuvo 20mg/0.4ml Pf Inj, 4 Pens
- Rasuvo 30mg/0.6ml Pf Inj, 4 Pens
- Rasuvo 7.5mg/0.15ml Pf Inj, 4 Pens
- Rasuvo 15mg Inj, 0.3ml
- Rasuvo 17.5mg Inj, 0.35ml
- Rasuvo 20mg Inj, 0.4ml
- Rasuvo 7.5mg Inj, 0.15ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:
Allergic reactions: Rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, difficulty breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Infections: Fever, chills, severe sore throat, ear or sinus pain, cough, increased or discolored sputum, painful urination, mouth sores, or a wound that won't heal.
Bleeding: Vomiting or coughing up blood, coffee ground-like vomit, blood in the urine, black, red, or tarry stools, bleeding gums, abnormal vaginal bleeding, unexplained bruises or bruises that get bigger, or uncontrollable bleeding.
Pancreatitis: Severe stomach pain, severe back pain, or severe nausea and vomiting.
Kidney problems: Inability to urinate, changes in urine output, blood in the urine, or sudden weight gain.
Liver problems: Dark urine, fatigue, decreased appetite, nausea or stomach pain, light-colored stools, vomiting, or yellow skin and eyes.
Lung or breathing problems: Shortness of breath, difficulty breathing, cough, or fever.
Nerve problems: Abnormal burning, numbness, or tingling sensations; weakness; or paralysis (inability to move a body part).
Other serious symptoms: Pinpoint red spots on the skin, severe dizziness or fainting, seizures, confusion, excessive sleepiness, changes in vision, bone pain, swelling, warmth, numbness, color changes, or pain in a leg or arm, weakness on one side of the body, speech or thinking difficulties, balance problems, drooping on one side of the face, or blurred vision, headache, or neck stiffness.
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. If you notice any of the following side effects or any other symptoms that bother you or don't go away, contact your doctor:
Decreased appetite
Hair loss
Dizziness, tiredness, or weakness
Stomach pain
Common cold symptoms
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Fever, chills, or other signs of infection
- Unusual bleeding or bruising
- Severe fatigue or weakness
- Yellowing of skin or eyes (jaundice)
- Dark urine or pale stools
- Severe nausea, vomiting, or diarrhea
- Mouth sores or ulcers
- New or worsening cough, shortness of breath
- Severe skin rash or peeling
- Swelling in ankles or feet
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced.
Certain health conditions, including:
+ Alcohol use disorder
+ Bone marrow disease, such as low white blood cell count, low platelet count, or anemia
+ Kidney disease
+ Liver disease
+ A weakened immune system
If you are breast-feeding, please note that you should not breast-feed while taking this medication. Additionally, you may need to avoid breast-feeding for a period after your last dose. Consult your doctor to determine the necessary duration for avoiding breast-feeding after completing the medication.
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. This will help ensure your safety while taking this medication. Never start, stop, or change the dose of any medication without first consulting your doctor to confirm it is safe to do so.
Precautions & Cautions
Before operating a vehicle or engaging in activities that require alertness, wait until you understand how this drug affects you. Be aware that you may have a higher risk of developing infections. To minimize this risk, practice good hygiene by washing your hands frequently and avoid close contact with individuals who have infections, colds, or flu.
Due to the potential for increased bleeding, exercise caution to avoid injuries. For personal grooming, use a soft-bristled toothbrush and an electric razor to reduce the risk of bleeding.
Prior to receiving any vaccinations, consult with your doctor, as certain vaccines may not be effective or may increase the risk of infection when taken with this medication. Additionally, discuss the consumption of alcohol with your doctor.
You may be more susceptible to sunburn; therefore, limit your exposure to the sun, sunlamps, and tanning beds. Use protective measures such as sunscreen, clothing, and eyewear to safeguard against the sun's harmful effects. Continue to protect yourself from sunburn for the duration recommended by your doctor.
If you experience excessive fluid loss, unusual sweating, vomiting, diarrhea, decreased appetite, or abnormal thirst, notify your doctor promptly. This medication has been associated with severe nervous system problems, which can be temporary or long-lasting and may worsen over time. In some cases, these problems may not resolve and can be fatal. If you have concerns, consult with your doctor.
If you have undergone radiation therapy, inform your doctor. Individuals aged 65 and older should use this medication with caution, as they may be more prone to side effects.
This drug may impact fertility, potentially leading to difficulties in becoming pregnant or fathering a child. It is unclear whether fertility will return to normal if this occurs. If you miss a menstrual period, have unprotected sex, or suspect that your birth control has failed, contact your doctor immediately.
Overdose Information
Overdose Symptoms:
- Severe bone marrow suppression (low blood counts)
- Severe mucositis (mouth sores)
- Gastrointestinal bleeding
- Liver damage
- Kidney failure
What to Do:
Seek immediate medical attention. The antidote is leucovorin (folinic acid), which helps to counteract the effects of methotrexate. Glucarpidase may be used in cases of delayed methotrexate clearance due to renal impairment. Call 1-800-222-1222 (Poison Control).
Drug Interactions
Contraindicated Interactions
- Live vaccines (due to immunosuppression)
- Trimethoprim/sulfamethoxazole (increased methotrexate levels and toxicity)
- Probenecid (decreased renal excretion of methotrexate)
- Salicylates (high dose) (decreased renal excretion of methotrexate)
- Non-steroidal anti-inflammatory drugs (NSAIDs) (caution, especially with high-dose methotrexate; can increase methotrexate levels and toxicity)
- Alcohol (increased risk of hepatotoxicity)
- Hepatotoxic agents (e.g., retinoids, azathioprine, sulfasalazine, leflunomide) (increased risk of hepatotoxicity)
- Nephrotoxic agents (e.g., cisplatin, aminoglycosides) (increased risk of methotrexate toxicity due to impaired renal clearance)
Major Interactions
- Folic acid antagonists (e.g., trimethoprim, pyrimethamine) (additive antifolate effects, increased toxicity)
- Proton pump inhibitors (PPIs) (e.g., omeprazole, pantoprazole) (may increase methotrexate levels, especially at high doses, by inhibiting renal elimination)
- Penicillins (e.g., amoxicillin, penicillin G) (may decrease renal clearance of methotrexate)
- Ciprofloxacin (may decrease renal clearance of methotrexate)
- Oral antibiotics (e.g., tetracyclines, chloramphenicol) (may alter gut flora, affecting methotrexate absorption/enterohepatic recirculation)
- Phenytoin (decreased phenytoin levels, increased methotrexate toxicity)
- Theophylline (decreased theophylline clearance)
- Sulfonamides (increased methotrexate toxicity)
Moderate Interactions
- Oral contraceptives (may decrease methotrexate levels)
- Cholestyramine (may decrease methotrexate absorption)
- L-asparaginase (antagonizes methotrexate effect)
- Nitrous oxide (may potentiate methotrexate toxicity by inhibiting methionine synthase)
Minor Interactions
- Not available
Monitoring
Baseline Monitoring
Rationale: To establish baseline hematologic status and detect myelosuppression.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline liver function and detect hepatotoxicity.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline renal function, as methotrexate is primarily renally cleared.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline pulmonary status and rule out pre-existing lung disease, given risk of pneumonitis.
Timing: Prior to initiation of therapy.
Rationale: To screen for viral hepatitis, which can increase risk of hepatotoxicity.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Weekly for the first month, then every 2-4 weeks for the next 2 months, then monthly or every 1-2 months thereafter.
Target: Maintain WBC >3,000/mm³, ANC >1,500/mm³, Platelets >100,000/mm³.
Action Threshold: Hold dose if significant drop in counts (e.g., WBC <3,000/mm³, ANC <1,500/mm³, Platelets <100,000/mm³). Consider dose reduction or discontinuation.
Frequency: Every 2-4 weeks for the first 2 months, then monthly or every 1-2 months thereafter.
Target: AST/ALT <2-3 times upper limit of normal (ULN).
Action Threshold: Hold dose if AST/ALT >3 times ULN. Consider liver biopsy if persistent elevations or cumulative dose concerns.
Frequency: Monthly or every 1-2 months.
Target: Within normal limits or stable baseline.
Action Threshold: Hold dose or reduce dose if creatinine increases by >50% or significantly above baseline.
Symptom Monitoring
- Signs of infection (fever, chills, sore throat)
- Unusual bleeding or bruising (petechiae, purpura)
- Fatigue, weakness, pallor (anemia)
- Oral ulcers, stomatitis, gingivitis
- Nausea, vomiting, diarrhea, abdominal pain
- Yellowing of skin or eyes (jaundice), dark urine, light-colored stools
- Shortness of breath, cough (especially dry, non-productive), chest pain
- Skin rash, itching
- Hair loss
- Headache, dizziness, confusion (rare, CNS toxicity)
Special Patient Groups
Pregnancy
Contraindicated in pregnant women with non-oncologic diseases due to significant risk of fetal death and severe birth defects (teratogenic effects).
Trimester-Specific Risks:
Lactation
Contraindicated. Methotrexate is excreted into breast milk and can cause serious adverse reactions in a breastfed infant.
Pediatric Use
Used in pediatric patients for Juvenile Idiopathic Arthritis (JIA) and certain oncologic indications. Dosing is typically weight or body surface area-based. Close monitoring for adverse effects is crucial, similar to adults.
Geriatric Use
Use with caution. Elderly patients may have reduced renal function, which can lead to increased methotrexate levels and toxicity. Close monitoring of renal function and blood counts is essential. Lower starting doses or less frequent dosing may be appropriate.
Clinical Information
Clinical Pearls
- Methotrexate is a weekly dose medication. Emphasize this to patients to prevent accidental daily dosing, which can be fatal.
- Folic acid supplementation (usually 1-5 mg once weekly, taken on a different day than methotrexate) is crucial to reduce common side effects like nausea, stomatitis, and liver enzyme elevations, without significantly compromising efficacy.
- Patients should be well-hydrated to promote renal excretion of methotrexate.
- Avoid concomitant use of NSAIDs, salicylates, and PPIs, especially with higher methotrexate doses, or use with extreme caution and close monitoring due to potential for increased methotrexate levels and toxicity.
- Educate patients on the importance of reporting any signs of infection, bleeding, or respiratory symptoms immediately.
- Liver biopsy may be considered for patients with persistent or progressive liver enzyme elevations, or after a certain cumulative dose, especially in psoriasis patients, though this practice is less common now with improved monitoring.
Alternative Therapies
- Other conventional synthetic DMARDs (e.g., sulfasalazine, hydroxychloroquine, leflunomide)
- Biologic DMARDs (e.g., TNF inhibitors like adalimumab, etanercept, infliximab; IL-6 inhibitors like tocilizumab; T-cell costimulation modulators like abatacept; B-cell depleting agents like rituximab)
- Targeted Synthetic DMARDs (tsDMARDs) / JAK inhibitors (e.g., tofacitinib, baricitinib, upadacitinib)
- Phototherapy (for psoriasis)
- Systemic corticosteroids (for acute flares, not long-term management)